AMD

PITTSBURGH, May 13, 2026 Renerva, Inc. announced the successful first-in-human implantation of its investigational PNM-CAP™ device, marking a major...

NORTHBROOK, Ill., May 12, 2026 Astellas Pharma US announced new clinical findings showing that IZERVAY® (avacincaptad pegol intravitreal solution)...

RAHWAY, N.J., April 2, 2026 Merck (MSD) has announced the initiation of a pivotal Phase 2b/3 clinical trial (MALBEC)...

BLOOMINGTON, Minn., USA, March 31, 2026 i-Lumen Scientific has received FDA Investigational Device Exemption (IDE) approval to initiate U.S....